These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1536809

  • 1. A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
    Stockschlaeder M, Storb R, Pepe M, Longton G, McDonald G, Anasetti C, Appelbaum F, Doney K, Martin P, Sullivan K.
    Br J Haematol; 1992 Jan; 80(1):49-54. PubMed ID: 1536809
    [Abstract] [Full Text] [Related]

  • 2. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
    Storb R, Deeg HJ, Pepe M, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J.
    Br J Haematol; 1989 Aug; 72(4):567-72. PubMed ID: 2673331
    [Abstract] [Full Text] [Related]

  • 3. Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Beelen DW, Quabeck K, Kaiser B, Wiefelspütz J, Scheulen ME, Graeven U, Grosse-Wilde H, Sayer HG, Schaefer UW.
    Transplantation; 1990 Sep; 50(3):421-7. PubMed ID: 2402791
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.
    Aschan J, Ringdén O, Sundberg B, Gahrton G, Ljungman P, Winiarski J.
    Bone Marrow Transplant; 1991 Feb; 7(2):113-9. PubMed ID: 2049554
    [Abstract] [Full Text] [Related]

  • 5. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease.
    Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J.
    Blood; 1986 Jul; 68(1):119-25. PubMed ID: 3521761
    [Abstract] [Full Text] [Related]

  • 6. A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
    Atkinson K, Biggs J, Concannon A, Dodds A, Young S, Wilson F, Ashby M, Downs K.
    Aust N Z J Med; 1991 Dec; 21(6):850-6. PubMed ID: 1818544
    [Abstract] [Full Text] [Related]

  • 7. Effect of post-transplant methotrexate, cyclosporin A and prednisolone on graft rejection after allogeneic bone marrow transplantation.
    Uharek L, Gassmann W, Fleischhauer D, Wottge HU, Loeffler H, Mueller-Ruchholtz W.
    Bone Marrow Transplant; 1991 Jan; 7(1):17-22. PubMed ID: 2043873
    [Abstract] [Full Text] [Related]

  • 8. Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
    Ringdén O, Klaesson S, Sundberg B, Ljungman P, Lönnqvist B, Persson U.
    Bone Marrow Transplant; 1992 Jan; 9(1):19-25. PubMed ID: 1543946
    [Abstract] [Full Text] [Related]

  • 9. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.
    Mrsić M, Labar B, Bogdanić V, Nemet D, Pavletić Z, Plavsić F, Dobrić I, Marusić M, Francetić I, Kastelan A.
    Bone Marrow Transplant; 1990 Aug; 6(2):137-41. PubMed ID: 2207450
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.
    Barrett AJ, Kendra JR, Lucas CF, Joss DV, Joshi R, Pendharkar P, Hugh-Jones K.
    Br Med J (Clin Res Ed); 1982 Jul 17; 285(6336):162-6. PubMed ID: 6807391
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
    Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V.
    N Engl J Med; 1986 Mar 20; 314(12):729-35. PubMed ID: 3513012
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
    Ringdén O, Bäckman L, Lönnqvist B, Heimdahl A, Lindholm A, Bolme P, Gahrton G.
    Bone Marrow Transplant; 1986 May 20; 1(1):41-51. PubMed ID: 3332119
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporin A versus methotrexate, followed by rescue with folinic acid as prophylaxis of acute graft-versus-host disease after bone marrow transplantation.
    Torres A, Martinez F, Gomez P, Herrera C, Rojas R, Gomez-Villagran JL, Garcia-Castellano JM, Velasco F, Andres P, Fornes G.
    Blut; 1989 Feb 20; 58(2):63-8. PubMed ID: 2645954
    [Abstract] [Full Text] [Related]

  • 14. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS, Kwak DH, Jeon YW, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Min WS, Lee JW.
    Biol Blood Marrow Transplant; 2017 Sep 20; 23(9):1498-1508. PubMed ID: 28554856
    [Abstract] [Full Text] [Related]

  • 15. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
    Byrne JL, Stainer C, Hyde H, Miflin G, Haynes AP, Bessell EM, Russell NH.
    Bone Marrow Transplant; 1998 Sep 20; 22(6):541-5. PubMed ID: 9758340
    [Abstract] [Full Text] [Related]

  • 16. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM, Geller RB, Lin LB, Dix SP, Holland HK, Maurer D, O'Toole K, Keller J, Connaghan DG, Heffner LT, Hillyer CD, Rodey GE, Winton EF, Maher RM, Fitzsimmons WE, Wingard JR.
    Biol Blood Marrow Transplant; 1997 Apr 20; 3(1):25-33. PubMed ID: 9209738
    [Abstract] [Full Text] [Related]

  • 17. Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease.
    Yau JC, LeMaistre CF, Zagars GK, Williams LA, Meneghetti CM, Luke DR, Dunphy FR, Spinolo JA, Jagannath S, Spitzer G.
    Bone Marrow Transplant; 1990 Apr 20; 5(4):269-72. PubMed ID: 2337738
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
    Bacigalupo A, Frassoni F, van Lint MT, Raffo MR, Vitale V, Corbetta G, Chierichetti S, Marmont AM.
    Exp Hematol; 1985 May 20; 13(4):244-8. PubMed ID: 3886417
    [Abstract] [Full Text] [Related]

  • 19. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA.
    Bone Marrow Transplant; 2001 Jul 20; 28(2):187-96. PubMed ID: 11509937
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japan.
    Koga Y, Nagatoshi Y, Kawano Y, Okamura J.
    Bone Marrow Transplant; 2003 Jul 20; 32(2):171-6. PubMed ID: 12838282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.